| For the past decade, Purvesh Khatri and team have been working on developing blood-based signatures for presence, type, and severity of infection. The signatures were exclusively licensed by Inflammatix, Inc., which a BMI postdoc, Tim Sweeney, and Khatri co-founded seven years ago. This week a test based on those signatures, TriVerity, received and FDA clearance. It is testament to the students and postdocs in our BMI program (now BDS) that enables translation from computation analysis to clinical care.
Huge congratulations! |
|
